On Monday, Biohaven Ltd (NYSE: BHVN) opened lower -13.06% from the last session, before settling in for the closing price of $27.65. Price fluctuations for BHVN have ranged from $26.57 to $55.72 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 26.44% at the time writing. With a float of $89.15 million, this company’s outstanding shares have now reached $101.22 million.
Let’s look at the performance matrix of the company that is accounted for 256 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Biohaven Ltd (BHVN) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Biohaven Ltd is 12.66%, while institutional ownership is 90.67%. The most recent insider transaction that took place on Mar 04 ’25, was worth 996,238. In this transaction Director of this company bought 32,700 shares at a rate of $30.47, taking the stock ownership to the 2,320,571 shares. Before that another transaction happened on Dec 30 ’24, when Company’s Director bought 29,000 for $35.94, making the entire transaction worth $1,042,393. This insider now owns 2,368,741 shares in total.
Biohaven Ltd (BHVN) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 26.44% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 22.04% during the next five years compared to -49.78% drop over the previous five years of trading.
Biohaven Ltd (NYSE: BHVN) Trading Performance Indicators
Check out the current performance indicators for Biohaven Ltd (BHVN). In the past quarter, the stock posted a quick ratio of 3.49.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -9.39, a number that is poised to hit -1.70 in the next quarter and is forecasted to reach -5.83 in one year’s time.
Technical Analysis of Biohaven Ltd (BHVN)
Biohaven Ltd (NYSE: BHVN) saw its 5-day average volume 1.39 million, a positive change from its year-to-date volume of 1.01 million. As of the previous 9 days, the stock’s Stochastic %D was 26.57%. Additionally, its Average True Range was 2.20.
During the past 100 days, Biohaven Ltd’s (BHVN) raw stochastic average was set at 7.67%, which indicates a significant decrease from 26.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 75.04% in the past 14 days, which was higher than the 63.71% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $34.81, while its 200-day Moving Average is $40.00. Nevertheless, the first resistance level for the watch stands at $26.52 in the near term. At $29.01, the stock is likely to face the second major resistance level. The third major resistance level sits at $31.53. If the price goes on to break the first support level at $21.51, it is likely to go to the next support level at $18.99. Assuming the price breaks the second support level, the third support level stands at $16.50.
Biohaven Ltd (NYSE: BHVN) Key Stats
There are currently 102,065K shares outstanding in the company with a market cap of 2.45 billion. Presently, the company’s annual sales total 0 K according to its annual income of -846,420 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -186,840 K.
